Hematopoietic Stem Cell Transplantation
Authors:
- John P. HigginsJHJohn P. Higgins
- Uma SundramUSUma Sundram
- Megan L. TroxellMTMegan L. Troxell
- 1 September 2014
- journal article
- review article
- Published by Wolters Kluwer Health in Advances in Anatomic Pathology
- Vol. 21 (5) , 301-320
Abstract
Hematopoietic stem cell transplantation (HCT), formerly known as bone marrow transplantation, is an integral part of treatment for many hematological malignancies. HCT is associated with several complications and comorbidities with differential effects on a wide spectrum of organs and tissues. We present an update on HCT-associated complications such as graft versus host disease (GVHD) and infection, with focus on the surgical pathology of the gastrointestinal (GI) tract, liver, and lung. Although the grading system for GI tract acute GVHD was proposed 40 years ago, recent studies have shed light on minimal histologic criteria for diagnosis of GVHD, as well as its differential diagnosis, including histologic effects of various medications. GI dysfunction in autologous transplant recipients is increasingly appreciated and patients are often biopsied. Acute liver injury in HCT is often due to sinusoidal obstruction syndrome (previously known as venoocclusive disease), or acute GVHD. Liver dysfunction at later time posttransplantation may be associated with acute or chronic GVHD, iron overload, or other causes of hepatitis. Lung injury in HCT is multifactorial, and it remains crucially important to diagnose and treat pulmonary infections. The pulmonary biopsy yields clinically unsuspected diagnoses in the majority of cases and its utilization is likely to increase. The pathology of the skin and kidney in HCT patients are detailed in accompanying articles.Keywords
This publication has 124 references indexed in Scilit:
- Thrombotic Microangiopathy Associated with Sirolimus Level after Allogeneic Hematopoietic Cell Transplantation with Tacrolimus/Sirolimus-Based Graft-versus-Host Disease ProphylaxisTransplantation and Cellular Therapy, 2013
- Advances in graft-versus-host disease biology and therapyNature Reviews Immunology, 2012
- Second Solid Tumors: Screening and Management Guidelines in Long-Term Survivors After Allogeneic Stem Cell TransplantationSeminars in Hematology, 2012
- Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host DiseaseTransplantation and Cellular Therapy, 2012
- An Official American Thoracic Society Research Statement: Noninfectious Lung Injury after Hematopoietic Stem Cell Transplantation: Idiopathic Pneumonia SyndromeAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Transplant‐associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimusPediatric Blood & Cancer, 2010
- Graft-versus-host diseaseThe Lancet, 2009
- Retinoic acid may increase the risk of bone marrow transplant nephropathyPediatric Nephrology, 2005
- Hepatic veno-occlusive disease and herbal teasThe Journal of Pediatrics, 1989
- Lymphocytic Bronchitis Associated with Graft-versus-Host Disease in Recipients of Bone-Marrow TransplantsNew England Journal of Medicine, 1978